Breaking News
November 18, 2018 - Scientists succeed in increasing stability, biocompatibility of light-transducing nanoparticles
November 18, 2018 - Sugar, a ‘sweet’ tool to understand brain injuries
November 18, 2018 - Pharmacist-Led Effort Cuts Inappropriate Rx in Older Adults
November 18, 2018 - Novel discovery could lead to new cancer, autoimmune disease therapy
November 18, 2018 - AHA and ADA launch new initiative to help people with type 2 diabetes reduce heart disease risk
November 18, 2018 - Balanced production of pro and anti-inflammatory cytokines at two years of age protects against malaria
November 18, 2018 - New pharmacological agent shows promise for prevention of heart rhythm disorders
November 18, 2018 - All That Social Media May Boost Loneliness, Not Banish It
November 18, 2018 - Scientists shine new light on link between obesity and cancer
November 18, 2018 - Risk factors for cardiovascular disease closely track with changes in diet patterns
November 18, 2018 - Biogen Scoops Sixth Prix Galien Award with UK Win for Life-Changing Rare Disease Medicine
November 18, 2018 - Detectable HIV-1 in treated human liver cells found to be inert
November 18, 2018 - Using light to control crucial step in embryonic development
November 18, 2018 - Unusual case of father-to-son HIV transmission reported
November 18, 2018 - FDA Approves Aemcolo (rifamycin) to Treat Travelers’ Diarrhea
November 18, 2018 - Poverty blamed on widening north-south gap in young adult deaths in England
November 18, 2018 - Progress in meningitis lags far behind other vaccine-preventable diseases, analysis shows
November 18, 2018 - Consensus Statement Issued on Management of Foot, Ankle Gout
November 18, 2018 - Fine particle air pollution is a public health emergency hiding in plain sight
November 18, 2018 - In-hospital mortality higher among patients with drug-resistant infections
November 17, 2018 - Research shines new, explanatory light on link between obesity and cancer
November 17, 2018 - FIND explores new diagnostic assays for confirmatory HCV diagnosis in community settings
November 17, 2018 - Tracking Preemies’ Head Size May Yield IQ Clues
November 17, 2018 - Scientists call for unified standards in 3-D genome and epigenetic data
November 17, 2018 - Lab Innovations 2018 has beaten all records by attracting 3,113 attendees
November 17, 2018 - New strategy to hinder emergence of antimicrobial-resistant pathogens
November 17, 2018 - Sexuality education before age 18 may reduce risk of sexual assault in college
November 17, 2018 - Reducing cellular proliferation could help deplete HIV reservoir and lead to a functional cure
November 17, 2018 - New model of FSHD could be useful to study effectiveness of experimental therapeutics
November 17, 2018 - FDA approves antibacterial drug to treat travelers’ diarrhea
November 17, 2018 - Lab Innovations 2018 confirmed as a major hit with visitors, exhibitors and speakers
November 17, 2018 - Largest parasitic worm genetic study hatches novel treatment possibilities
November 17, 2018 - UCLA biologists uncover how head injuries can lead to serious brain disorders
November 17, 2018 - Static and dynamic physical activities offer varying protection against heart disease
November 17, 2018 - Obesity significantly increases risk of Type 2 diabetes and coronary artery disease
November 17, 2018 - Researchers show how proteins interact in hypoxic conditions to facilitate mitochondrial fission
November 17, 2018 - People with rare cancers can benefit from genomic profiling, shows research
November 17, 2018 - NIH awards over $1.8 million to husband-and-wife doctors to test new breast cancer approach
November 17, 2018 - Four-in-one antibody used to fight flu shows promise in mice
November 17, 2018 - New approach allows pathogens to be starved by blocking important enzymes
November 17, 2018 - Higher body mass index could cause depression even without health problems
November 17, 2018 - Protein which plays role in sensing cell damage serves as new target to treat pulmonary hypertension
November 17, 2018 - FDA Approves Adcetris (brentuximab vedotin) in Combination with Chemotherapy for Adults with Previously Untreated Systemic Anaplastic Large Cell Lymphoma or Other CD30-Expressing Peripheral T-Cell Lymphomas
November 17, 2018 - ID specialist input improves outcomes for outpatient parenteral antimicrobial therapy
November 17, 2018 - UT Southwestern scientists selected to receive 2019 Edith and Peter O’Donnell Awards
November 17, 2018 - New clinical algorithm to help individuals manage type 2 diabetes when fasting during Ramadan
November 17, 2018 - Researchers identify LZTR1 as evolutionarily conserved component of RAS pathway
November 17, 2018 - Heart Disease Leading Cause of Death in Low-Income Counties
November 17, 2018 - Estrogen Levels Test: MedlinePlus Lab Test Information
November 17, 2018 - Research reveals link between immunity, diabetes
November 17, 2018 - Research shows how to achieve improved smoking cessation outcomes within California’s Medicaid population
November 17, 2018 - New study finds less understanding and implementation of patient engagement
November 17, 2018 - New shoe insole technology could help diabetic ulcers heal better while walking
November 17, 2018 - New method to extend cell division and immortalization of avian-derived cells
November 17, 2018 - Australian Academy of Science urges parents to vaccinate children against meningococcal disease
November 17, 2018 - Hot water treatment may help improve inflammation and metabolism in sedentary people
November 17, 2018 - Researchers produce 3D chemical maps of small biological samples
November 17, 2018 - Must Blood Pressure Rise Wth Age? Remote Tribes Hold Clues
November 17, 2018 - Noonan Syndrome
November 17, 2018 - Interventions to delay and prevent type 2 diabetes are underused, researchers say
November 17, 2018 - Hackathon prize winner seeks to remotely monitor patient skin conditions
November 17, 2018 - Research team identifies Ashkenazi Jewish founder mutation for Leigh syndrome
November 17, 2018 - Gene editing could be used to halt kidney disease in patients with Joubert syndrome
November 17, 2018 - Study uncovers link between gut disruption and aging
November 17, 2018 - Teens more likely to pick up smoking after exposure from friends and family
November 17, 2018 - Nicoya designate the Institute for Stem Cell Biology and Regenerative Medicine as the OpenSPR Centre of Excellence
November 17, 2018 - new horizon in dental, oral and craniofacial research
November 17, 2018 - How does poor air quality affect your health?
November 17, 2018 - New device can regulate children’s blood glucose more like natural pancreas
November 17, 2018 - Game-Changers in Western Blotting and Protein Analysis
November 17, 2018 - FDA announces new actions to limit sale of e-cigarettes to youth
November 17, 2018 - Warmer winter temperatures related to higher crime rates
November 17, 2018 - MCO places increasing emphasis on helping people find and access healthy food
November 17, 2018 - Group of students aim to improve malaria diagnosis using old smartphones
November 17, 2018 - Transplantation of feces may protect preterm children from deadly bowel disease
November 17, 2018 - Researchers explore whether low-gluten diets can be recommended for people without allergies
November 17, 2018 - New and better marker for assessing patients after cardiac arrest
November 17, 2018 - For 7-year-old with failing bone marrow, a life-saving transplant | News Center
November 17, 2018 - New first-line treatment for peripheral T-cell lymphoma approved by FDA
November 17, 2018 - Artificial intelligence could be valuable tool to help young victims disclose traumatic testimony
The Digital Health Platform That’s Tackling Chronic Health Conditions

The Digital Health Platform That’s Tackling Chronic Health Conditions

image_pdfDownload PDFimage_print

An interview with Simon Pickup, UK Managing Director of Liva Healthcare, about the Liva digital health platform and how it can be used to help patients change their lives for the better.

Heart disease and diabetes are amongst the biggest killers in the world today. How can lifestyle apps such as those offered by Liva Healthcare help to reduce the prevalence of these diseases and save lives?

The Liva digital health platform is all about changing lifestyles for the better. We help patients improve their lifestyle through a process called behavioral change therapy.

Lifestyle change, woman starting to runImage Credit: LMproduction / Shutterstock

Patients are given individual goals that range from eating smaller portion sizes, increasing the amount of exercise they do, even improving sleep patterns, all of which have been linked to chronic disease.

How does the Liva app work?

The program is a combination of a professional health coach and our state-of-the-art digital platform. The patient initially meets up with a health coach who comes up with an individualized health plan. Everybody has a different plan depending on their needs, and the condition they are suffering with.

During the hour, incremental step changes in the form of goals are put into place. The patient then uses the platform to manage their health and meet these goals. The coach can see everything the participant is doing through the platform and is able to help the patient meet their goals.

The platform isn’t just for one chronic condition. It is suitable for all chronic conditions. For example, patients with Type 2 diabetes often have lots of co-morbidities that need to be taken into consideration before recommending a health plan.

The NHS program for diabetes prevention is currently 12 months. We have set-interval coaching throughout this period and at any point in time, the coach can monitor the performance of all the patients that they are managing, which, in turn, helps drive efficiency.

Liva app

What types of lifestyle changes does the app recommend? Why is it so effective at helping people to lose weight?

There are a number of goals that are available on the platform, and we’re releasing new ones all the time, depending on the condition that the patient is suffering with.

There are around 20 goals at the moment, and as I said earlier, it’s about setting individual goals for that particular patient. Not everybody follows the same plan, and the focus of each plan is different.

Once they’ve achieved or attained that goal, we either switch that goal off and turn another one on or increase their goal settings.

To give you an example, our clinical studies have shown that not only can patients lose 7.4kg within the first four months but they are actually able to sustain this weight loss 20 months later. Which is about 7.2% of their BMI. We have published results like these in several reputable journals.

It takes about three months in general to change a lifestyle, but it can take up to 18 months to keep that lifestyle. This isn’t a fad diet. It’s about momentum. Slow, incremental changes that help patients change their lifestyle permanently.

It’s about getting people to slowly, incrementally change the way they live, which means that they will stick to it. It becomes a permanent lifestyle change.

Do you think that every patient in the UK should use a lifestyle app? If yes, what age would you recommend that people start using them?

Interestingly, my ten-year-old daughter has a lifestyle app. I think it’s more of a craze than actually doing anything with it. But you know what? It’s been proven that children as young as 5 could do with a change of their lifestyle, which is a really scary statistic.

For us, it’s about educating the adults to change their lifestyles and then hopefully that knowledge will be passed on to the next generation. There are lots of school initiatives with famous chefs to improve the way our children are eating in school, and that helps too.

How can healthcare apps such as Liva help to reduce the economic pressures faced by today’s NHS?

We currently offer our program as a pilot in two regions for the NHS; in Humber, Coast and Vale and North East London. We’d like to extend our service to more regions, for example, to CCG’s in different regions that manage diabetics, but also to CCGs who manage other chronic diseases, for example, respiratory diseases.

We’re also looking to partner with pharmaceutical companies to improve outcomes for patients using one of their products. We’re just about to start a pilot with one particular pharmaceutical company in two regions globally.

Liva has been proven to reduce the costs faced by the NHS, simply because we are able to improve people’s lifestyles. For example, patients who successfully use the platform are able to reverse their Type 2 diabetes, and others are no longer at risk of developing diabetes. This allows us to reduce the cost burden of medication on the NHS.

The cost for a Type 2 diabetic with severe complications is around £35,000 a year. On average, we can prove that per patient we can save around €2,000 in societal cost savings.

This doesn’t seem like a lot of money, but if you multiply it by a huge cohort of patients, it’s huge savings.

Where can readers find more information?

For more information, head to the Liva Healthcare website.

About Liva Healthcare

Founded in 2014, Liva Healthcare is an innovative digital health coaching platform for scalable lifestyle and disease management.  

Winner of ‘Health IT Firm of the Year’ at the HealthInvestor Awards 2018 and ‘Healthtech Innovators of the Year – Europe at the Global Health & Pharma Awards 2018, Liva Healthcare is used by public health care, private insurance and pharma companies including NHS England, AXA PPP Healthcare and Copenhagen Municipality.  

Liva Healthcare’s platform facilitates ongoing personalised health coaching through an intuitive platform, building strong bond between coach, GP and patient. Its focus lies on tackling chronic illnesses, such as Type 2 diabetes, obesity and heart disease, by driving behaviour change.   

Currently being used in Denmark, UK and Sweden, the platform is multilingual across several languages. It has proven to work efficiently across all socio-economic backgrounds and is capable of engaging groups normally hard to reach.

It is based upon nine to 18 months of continuous patient engagement to make new habits and behaviours stick. One coach can manage 500 patients per year simultaneously without the loss of patient outcomes.  

Implementation time from get-go is normally within weeks and the platform is available as a white-label SaaS platform, or as a turn-key solution, dependent on client specifications.  

Liva Healthcare has offices in Copenhagen, Denmark and London, UK.  

Liva Healthcare logo

Tagged with:

About author

Related Articles